These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8301099)

  • 21. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
    Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.
    Pals DT; Couch SJ
    Clin Exp Hypertens; 1993 Jan; 15(1):1-13. PubMed ID: 8385523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
    Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
    Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    Clin Exp Hypertens; 1997; 19(5-6):937-51. PubMed ID: 9247766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal man.
    Doig JK; MacFadyen RJ; Sweet CS; Lees KR; Reid JL
    J Cardiovasc Pharmacol; 1993 May; 21(5):732-8. PubMed ID: 7685442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
    J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
    Pals DT; DeGraaf GL; Couch SJ; Brunden MN
    Clin Exp Hypertens A; 1991; 13(3):425-36. PubMed ID: 1893613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
    Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
    J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
    Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D
    J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
    Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
    Prescott MF; Webb RL; Reidy MA
    Am J Pathol; 1991 Dec; 139(6):1291-6. PubMed ID: 1750504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
    Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
    Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracerebroventricular angiotensin II-induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112B.
    Beresford MJ; Fitzsimons JT
    Exp Physiol; 1992 Sep; 77(5):761-4. PubMed ID: 1418958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of angiotensins I, II, and III in pulmonary vascular bed of the rat.
    Nossaman BD; Feng CJ; Wang J; Kadowitz PJ
    Am J Physiol; 1994 Apr; 266(4 Pt 1):L389-96. PubMed ID: 8179016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive activity of the novel, nonpeptide angiotensin II receptor antagonists BIBS 39 and BIBS 222 in conscious renal hypertensive rats.
    Zhang J; Van Meel JC; Van Zwieten PA
    Pharmacology; 1993 May; 46(5):241-7. PubMed ID: 8488169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
    Siragy HM; Carey RM
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1103-7. PubMed ID: 9321892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.